Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -163.00K | -132.10K | -243.60K | -368.60K | -281.90K |
| Total Depreciation and Amortization | 36.60K | 40.20K | 43.90K | 43.50K | 44.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.30K | 32.70K | 17.10K | 24.50K | 26.20K |
| Change in Net Operating Assets | 53.30K | 76.20K | 65.90K | 92.40K | 276.30K |
| Cash from Operations | -50.80K | 17.00K | -116.70K | -208.20K | 65.00K |
| Capital Expenditure | -3.60K | -15.50K | -7.20K | -64.70K | -17.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 35.00K | 52.50K |
| Cash from Investing | -3.60K | -15.50K | -7.20K | -29.70K | 35.40K |
| Total Debt Issued | 0.00 | 82.40K | 175.00K | 50.00K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 82.40K | 175.00K | 50.00K | 0.00 |
| Foreign Exchange rate Adjustments | 13.40K | -63.50K | 16.90K | -6.90K | -96.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.00K | 20.40K | 68.00K | -194.70K | 3.70K |
